Rethinking remdesivir: Researchers modify current drug, creating oral version that can be taken earlier in COVID-19 diagnoses

In a new paper, researchers describe cell and animal studies that demonstrate how lipid modifications of remdesivir nucleoside can improve drug delivery, effectiveness and toxicity compared to remdesivir.

source https://www.sciencedaily.com/releases/2021/08/210803105515.htm